Regression models for group testing data with pool dilution effects.

Group testing is widely used to reduce the cost of screening individuals for infectious diseases. There is an extensive literature on group testing, most of which traditionally has focused on estimating the probability of infection in a homogeneous population. More recently, this research area has shifted towards estimating individual-specific probabilities in a regression context. However, existing regression approaches have assumed that the sensitivity and specificity of pooled biospecimens are constant and do not depend on the pool sizes. For those applications, where this assumption may not be realistic, these existing approaches can lead to inaccurate inference, especially when pool sizes are large. Our new approach, which exploits the information readily available from underlying continuous biomarker distributions, provides reliable inference in settings where pooling would be most beneficial and does so even for larger pool sizes. We illustrate our methodology using hepatitis B data from a study involving Irish prisoners.

[1]  S Vansteelandt,et al.  Regression Models for Disease Prevalence with Diagnostic Tests on Pools of Serum Samples , 2000, Biometrics.

[2]  Christopher S. McMahan,et al.  Informative Dorfman Screening , 2012, Biometrics.

[3]  N. Perkins,et al.  Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples , 2005, Epidemiology.

[4]  G. Casella,et al.  Statistical Inference , 2003, Encyclopedia of Social Network Analysis and Mining.

[5]  J L Gastwirth,et al.  The efficiency of pooling in the detection of rare mutations. , 2000, American journal of human genetics.

[6]  S. M. Samuels On the Number of Successes in Independent Trials , 1965 .

[7]  C. Farrington Estimating prevalence by group testing using generalized linear models. , 1992, Statistics in medicine.

[8]  M. Currie,et al.  Pooling of Clinical Specimens Prior to Testing for Chlamydia trachomatis by PCR Is Accurate and Cost Saving , 2004, Journal of Clinical Microbiology.

[9]  Paul S Albert,et al.  Pooling Designs for Outcomes under a Gaussian Random Effects Model , 2012, Biometrics.

[10]  R. Dorfman The Detection of Defective Members of Large Populations , 1943 .

[11]  B. Kubanek,et al.  Mini‐pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results , 1998, Transfusion.

[12]  Enrique F Schisterman,et al.  Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures , 2008, Statistics in medicine.

[13]  P. Hall,et al.  Nonparametric regression with homogeneous group testing data , 2012, 1205.6102.

[14]  Joanna Lynn Lewis,et al.  Cost savings and increased efficiency using a stratified specimen pooling strategy for Chlamydia trachomatis and Neisseria gonorrhoeae. , 2012, Sexually transmitted diseases.

[15]  S. Stanley Young,et al.  Statistical Design of Pools Using Optimal Coverage and Minimal Collision , 2006, Technometrics.

[16]  W. Swallow,et al.  Robustness of Group Testing in the Estimation of Proportions , 1999, Biometrics.

[17]  M Xie,et al.  Regression analysis of group testing samples , 2001, Statistics in medicine.

[18]  Lawrence M. Wein,et al.  Pooled Testing for HIV Screening: Capturing the Dilution Effect , 2018, Oper. Res..

[19]  Bin Wang,et al.  Deconvolution Estimation in Measurement Error Models: The R Package decon. , 2011, Journal of statistical software.

[20]  On the viral safety of plasma pools and plasma derivatives , 2005 .

[21]  Joshua M Tebbs,et al.  Group Testing Regression Models with Fixed and Random Effects , 2009, Biometrics.

[22]  David M. Warshauer,et al.  Pooling Nasopharyngeal/Throat Swab Specimens To Increase Testing Capacity for Influenza Viruses by PCR , 2011, Journal of Clinical Microbiology.

[23]  E. Seifried,et al.  Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism , 2005, Transfusion.

[24]  X M Tu,et al.  Studies of AIDS and HIV surveillance. Screening tests: can we get more by doing less? , 1994, Statistics in medicine.

[25]  Xianzheng Huang,et al.  An improved test of latent‐variable model misspecification in structural measurement error models for group testing data , 2009, Statistics in medicine.

[26]  William C Miller,et al.  Detection of acute infections during HIV testing in North Carolina. , 2005, The New England journal of medicine.

[27]  Hae-Young Kim,et al.  Comparison of Group Testing Algorithms for Case Identification in the Presence of Test Error , 2007, Biometrics.

[28]  L. Wein,et al.  Pooled testing for HIV prevalence estimation: exploiting the dilution effect. , 2015, Statistics in medicine.

[29]  A. Meister,et al.  Nonparametric Regression Analysis for Group Testing Data , 2011 .

[30]  Peter Tomasulo,et al.  Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. , 2005, The New England journal of medicine.

[31]  J. Parry,et al.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey , 2000, BMJ : British Medical Journal.